Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ANIXA BIOSCIENCES INC (ANIX : NSDQ)

• Company Description    Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $2.82 Daily Weekly Monthly 20 Day Moving Average: 196,728 shares Shares Outstanding: 33.38 (millions) Market Capitalization: $94.13 (millions) Beta: 0.53 52 Week High: $5.46 52 Week Low: $2.33 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.60% -10.26% 12 Week -35.02% -37.24% Year To Date -9.62% -9.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3150 ALMADEN EXPRESSWAY SUITE 250 - SAN JOSE,CA 95118 USA ph: 408-708-9808 fax: 631-549-5974 skilmer@anixa.com http://www.anixa.com

• General Corporate Information    Officers Amit Kumar - Chief Executive Officer and Chairman Michael J. Catelani - President; Chief Operating Officer and Chief Finan Lewis H. Titterton, Jr. - Director Arnold Baskies - Director Emily Gottschalk - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 03528H109 SIC: 2834 Fiscal Year Fiscal Year End: October Last Reported Quarter: 10/01/25 Next Expected EPS Date: 03/10/26 Share - Related Items Shares Outstanding: 33.38 Most Recent Split Date: 6.00 (0.04:1) Beta: 0.53 Market Capitalization: $94.13 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.36 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.65 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -28.57% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 01/31/26 - - 10/31/25 - -71.68 07/31/25 - -67.45 ROA 01/31/26 - - 10/31/25 - -62.79 07/31/25 - -59.18 Current Ratio 01/31/26 - - 10/31/25 - 8.08 07/31/25 - 8.45 Quick Ratio 01/31/26 - - 10/31/25 - 8.08 07/31/25 - 8.45 Operating Margin 01/31/26 - - 10/31/25 - - 07/31/25 - - Net Margin 01/31/26 - - 10/31/25 - - 07/31/25 - - Pre-Tax Margin 01/31/26 - - 10/31/25 - - 07/31/25 - - Book Value 01/31/26 - - 10/31/25 - 0.42 07/31/25 - 0.48 Inventory Turnover 01/31/26 - - 10/31/25 - - 07/31/25 - - Debt-to-Equity 01/31/26 - - 10/31/25 - 0.00 07/31/25 - 0.00 Debt-to-Capital 01/31/26 - - 10/31/25 - 0.00 07/31/25 - 0.00

Powered by Zacks Investment Research ©